Non-apnea Electrical Impedance Tomography for Bedside Ventilation-Perfusion Assessment: a Prospective Cross-over Validation Study
NELSB
Non-apnea Saline-contrast EIT for Lung Perfusion Imaging in Spontaneously Breathing Patients: A Prospective Cross-over Study
1 other identifier
interventional
24
1 country
1
Brief Summary
Title: Validating the Accuracy of Lung Blood Flow Monitoring Without Breath-Holding Under Spontaneous Breathing Support Purpose: The purpose of this study is to evaluate the accuracy of a new Electrical Impedance Tomography (EIT) technique that measures lung blood flow (perfusion) without requiring patients to hold their breath. We aim to determine if this "non-apnea" method provides results consistent with the current clinical gold standard (the "pause" method). Background: EIT is a non-invasive bedside tool used to monitor lung function. The traditional method for measuring lung blood flow requires patients to hold their breath for 5-8 seconds during a saline injection to avoid interference from breathing. However, many patients-especially those using a nasal cannula, high-flow nasal oxygen (HFNO), or pressure support ventilation (PSV)-must maintain continuous spontaneous breathing and find it difficult or unsafe to hold their breath. If a "non-apnea" method is proven accurate, it will make monitoring safer and easier for these patients. What the Study Involves: The study includes stable adult patients who are breathing spontaneously. Each patient undergoes two measurements in a randomized order: Standard Reference (Pause Method): Measurement taken during a brief, guided breath-hold. Test Method (Non-Apnea Method): Measurement taken during normal, uninterrupted breathing while receiving respiratory support (Nasal Cannula, HFNO, or PSV). Expected Significance: By comparing the lung images and ventilation/perfusion (V/Q) data from both methods, this study seeks to validate the reliability and precision of the non-apnea approach. This would allow clinicians to assess lung health in spontaneously breathing patients without interrupting their natural breathing rhythm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2026
CompletedStudy Start
First participant enrolled
March 19, 2026
CompletedFirst Posted
Study publicly available on registry
March 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2026
CompletedApril 23, 2026
January 1, 2026
25 days
March 18, 2026
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Spearman correlation coefficient (r)
The Spearman correlation coefficient will be calculated to assess the voxel-by-voxel agreement of lung perfusion maps generated by the non-apnea algorithm compared to the reference standard (breath-hold method).
Within 30 minutes
Study Arms (2)
Standard Breath-hold Method
ACTIVE COMPARATOR1. This arm serves as the reference standard for EIT perfusion measurement. 2. A 10 mL bolus of 10% NaCl is injected during a 5-8 second end-expiratory pause. 3. For patients on Nasal Cannula or HFNO, the pause is achieved via coached respiratory instruction; for patients on PSV, the ventilator's end-expiratory hold function is used
Non-apnea Method
EXPERIMENTAL1. This arm evaluates the feasibility and accuracy of perfusion measurement during uninterrupted breathing. 2. A 10 mL bolus of 10% NaCl is injected while the patient maintains a natural, continuous breathing rhythm. 3. This method is tested across all included respiratory support modes, including Nasal Cannula, HFNO, and PSV, without any respiratory pause or instruction.
Interventions
Participants receive a central venous bolus injection of 10 mL 10% NaCl. Lung perfusion is then assessed using Electrical Impedance Tomography (EIT). The intervention evaluates two acquisition conditions: one during a brief respiratory pause (reference) and one during uninterrupted spontaneous breathing (test).
Eligibility Criteria
You may qualify if:
- Patients aged ≥ 18 years.
- Requiring respiratory support including Nasal Cannula, High-Flow Nasal Oxygen (HFNO), or Pressure Support Ventilation (PSV).
- Hemodynamically stable.
- Able to tolerate a brief respiratory pause (for the reference group).
- Signed informed consent.
You may not qualify if:
- Pregnancy or breastfeeding.
- Contraindications to electrical impedance tomography (e.g., cardiac pacemaker, skin integrity issues on the chest).
- Severe circulatory failure or cardiogenic shock.
- Known allergy to hypertonic saline.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hongping Qu
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2026
First Posted
March 24, 2026
Study Start
March 19, 2026
Primary Completion
April 13, 2026
Study Completion
April 13, 2026
Last Updated
April 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share